Recent studies on patients with a history of pre-HAART drug resistance, but currently on a successful regimen, provided new insights into the dynamics of the latent cellular viral reservoir. Results indi-cated that the latent reservoir is an archive, composed of a mixture of wild-type and drug-resistant strains. The studies showed that, even after years of successful HAART, the wild-type viral strains that circulated before the initiation of the therapy as well as all the different drug-resistant viral strains that evolved over time during eventual periods of non-suppressive treatment, remain detectable in the pro-viral reservoir. These findings support the hypothesis that during active viral replication, new variants, including drug-resist...
Human immunodeficiency virus type 1 (HIV-1) persists in a latent reservoir of infected resting memor...
In patients who are receiving prolonged antiretroviral treatment (ART), HIV can persist within a sma...
Ahmad R Sedaghat is with Johns Hopkins University School of Medicine, Janet D Siliciano is with John...
Recent studies on patients with a history of pre-HAART drug resistance, but currently on a successfu...
Despite the remarkable success of highly active antiretroviral therapy (HAART) for the treatment of ...
Since the advent of antiretroviral therapy (ART), morbidity and mortality rates in those infected wi...
AbstractSince the advent of antiretroviral therapy (ART), morbidity and mortality rates in those inf...
Although antiretroviral therapy (ART) is highly effective at suppressing HIV-1 replication, the viru...
Despite our ability to suppress HIV-1 replication indefinitely in people on optimal combined antiret...
Despite our ability to suppress HIV-1 replication indefinitely in people on optimal combined antiret...
The aim of this study was to determine whether drug-resistant virus persists in peripheral blood mon...
The persistence of infected T cells harbouring intact HIV proviruses is the barrier to the eradicati...
The introduction of highly active antiretroviral therapy (HAART) has been an important breakthrough ...
peer reviewedOBJECTIVE: HIV-1 reservoirs are the major hurdle to virus clearance in combination anti...
AbstractHIV-1 infection and compartmentalization in diverse leukocyte targets significantly contribu...
Human immunodeficiency virus type 1 (HIV-1) persists in a latent reservoir of infected resting memor...
In patients who are receiving prolonged antiretroviral treatment (ART), HIV can persist within a sma...
Ahmad R Sedaghat is with Johns Hopkins University School of Medicine, Janet D Siliciano is with John...
Recent studies on patients with a history of pre-HAART drug resistance, but currently on a successfu...
Despite the remarkable success of highly active antiretroviral therapy (HAART) for the treatment of ...
Since the advent of antiretroviral therapy (ART), morbidity and mortality rates in those infected wi...
AbstractSince the advent of antiretroviral therapy (ART), morbidity and mortality rates in those inf...
Although antiretroviral therapy (ART) is highly effective at suppressing HIV-1 replication, the viru...
Despite our ability to suppress HIV-1 replication indefinitely in people on optimal combined antiret...
Despite our ability to suppress HIV-1 replication indefinitely in people on optimal combined antiret...
The aim of this study was to determine whether drug-resistant virus persists in peripheral blood mon...
The persistence of infected T cells harbouring intact HIV proviruses is the barrier to the eradicati...
The introduction of highly active antiretroviral therapy (HAART) has been an important breakthrough ...
peer reviewedOBJECTIVE: HIV-1 reservoirs are the major hurdle to virus clearance in combination anti...
AbstractHIV-1 infection and compartmentalization in diverse leukocyte targets significantly contribu...
Human immunodeficiency virus type 1 (HIV-1) persists in a latent reservoir of infected resting memor...
In patients who are receiving prolonged antiretroviral treatment (ART), HIV can persist within a sma...
Ahmad R Sedaghat is with Johns Hopkins University School of Medicine, Janet D Siliciano is with John...